Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions by Jack Wallace, Jacqueline Richmond, Jessica Howell, Behzad Hajarizadeh, Jennifer Power, Carla Treloar, Peter A. Revill, Benjamin Cowie, Su Wang, Mark Stoové, Alisa Pedrana, Margaret Hellard

“…The World Health Organization has committed to eliminating viral hepatitis as a public health threat by 2030, with future curative hepatitis B interventions potentially revolutionizing public health responses to hepatitis B, and being essential for viral hepatitis elimination. …”
Get full text

Epidemiology and course of infectious diseases during the COVID-19 pandemic. Report 1. HIV infection, hepatitis c and tuberculosis by Nikolay A. Belyakov, Ekaterina V. Boeva, Zinaida M. Zagdyn, Elena V. Esaulenko, Dmitry A. Lioznov, Olga E. Simakina

“…The absence of a negative effect of COVID-19 on mortality rates in HIV infection, viral hepatitis C and tuberculosis in the territories of the NWFD was noted. …”
Get full text

The Value of Serum CHI3L1 for the Diagnosis of Chronic Liver Diseases by Qiu H, Zhang X

“…Hanyu Qiu, Xiaomei Zhang Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People’s Republic of ChinaCorrespondence: Xiaomei Zhang, Department of Gastroenterology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, 410008, People’s Republic of China, Tel: +86 731 8432 7331, Email zhangxm315@csu.edu.cnObjective: To explore the value of chitinase-3-like protein 1 (CHI3L1) for the diagnosis of patients with chronic liver diseases such as chronic viral hepatitis B, liver cirrhosis and hepatocellular carcinoma (HCC), and analyze the correlation between serum CHI3L1 level and Child–Pugh grading of chronic liver diseases.Methods: The serum CHI3L1 levels of 154 cases of chronic viral hepatitis B, 132 cases of liver cirrhosis and 88 cases of HCC were detected by ELISA, and 92 healthy subjects were taken as the control.Results: The –serum CHI3L1 levels in HCC group, liver cirrhosis group and chronic viral hepatitis B group were higher than in healthy control group (P < 0.001). …”
Get full text

Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by... by Nelly R. Mugo, Nelly R. Mugo, Victor Mudhune, Renee Heffron, Renee Heffron, Katherine K. Thomas, Eleanor McLellan-Lemal, Betty Njoroge, Sue Peacock, Siobhán M. O’Connor, Beatrice Nyagol, Eunice Ouma, Renee Ridzon, Jeffrey Wiener, Nina Isoherranen, David W. Erikson, Louise A. Ouattara, Nazita Yousefieh, Terry A. Jacot, Richard E. Haaland, Susan A. Morrison, Harald S. Haugen, Andrea R. Thurman, Shannon A. Allen, Jared M. Baeten, Jared M. Baeten, Jared M. Baeten, Taraz Samandari, Taraz Samandari, Gustavo F. Doncel

Get full text

Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United States by Ram K. Shrestha, Robyn Neblett Fanfair, Liisa M. Randall, Crystal Lucas, Lisa Nichols, Nasima Camp, Kathleen A. Brady, Heidi Jenkins, Frederick L. Altice, Alfred DeMaria, Merceditas Villanueva, Paul J. Weidle

Get full text

Factors Associated with Virological Failure in First-Line Antiretroviral Therapy in Patients Diagnosed with HIV-1 between 2010 and 2018 in Israel by Tali Wagner, Itzchak Levy, Daniel Elbirt, Eduardo Shahar, Karen Olshtain-Pops, Hila Elinav, Michal Chowers, Valery Istomin, Klaris Riesenberg, Dikla Geva, Neta S. Zuckerman, Marina Wax, Rachel Shirazi, Yael Gozlan, Natasha Matus, Shirley Girshengorn, Rotem Marom, Ella Mendelson, Orna Mor, Dan Turner

Get full text

Do Patients with Autoimmune Conditions Have Less Access to Liver Transplantation despite Superior Outcomes? by Stephanie S. Keeling, Malcolm F. McDonald, Adrish Anand, Cameron R. Goff, Caroline R. Christmann, Spencer C. Barrett, Michael Kueht, John A. Goss, George Cholankeril, Abbas Rana

“…Patients with AutoD had significantly better post-transplant patient and graft survival than ALD, HCC, viral hepatitis, and NASH in each and across all eras (<i>p</i>-values all < 0.001). …”
Get full text

ALTA: a simple nutritional prognostic score for patients with hepatitis B virus-related acute-on-chronic liver failure by Rui Song, Xiaohao Wang, Zhao Li, Hongyu Wu, Jiahe Tan, Junyi Tan, Hanlu Li, Teng Zeng, Hong Ren, Zhiwei Chen

Get full text

Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco by Sayeh Ezzikouri, Raji Tajudeen, Hind Majidi, Soad Redwane, Safaa Aqillouch, Mohammed Abdulaziz, Merawi Aragaw, Mosoka Papa Fallah, Senga Sembuche, Serge Batcho, Patrick Kabwe, Elizabeth Gonese, Oumaima Laazaazia, Mohcine Elmessaoudi-Idrissi, Nadia Meziane, Abdelhakim Ainahi, M’hammed Sarih, Ahmed E. Ogwell Ouma, Abderrahmane Maaroufi

Get full text

Cultural and linguistic diversity of people living with chronic hepatitis B in 2011–2016: changing migration, shifting epidemiology by Jennifer H. MacLachlan, Benjamin C. Cowie

Get full text

Autoimmune Hepatitis: Report of Two Cases with Different Clinical Manifestations by Şua SÜMER, Nebahat DİKİCİ, Ertuğrul KAYAÇETİN, Eda KATLANIR, Onur URAL

“…Clinical course of autoimmune hepatitis resembles viral hepatitis. However, atypical manifestations characterized by cholestasis can also be observed. …”
Get full text

CD73, a significant protein in liver diseases by Huilian Shi, Heng Dai, Qianqian Sun, Siliang Wang, Yuanyuan Chen

“…This paper aims to summarize the relevant effects of CD73 in the occurrence, development and prognosis of liver diseases such as viral hepatitis, highlight the important role of CD73 in liver diseases, especially in viral hepatitis such as HBV and HCV, and explore new clinical ideas for future treatment targets of liver diseases.…”
Get full text

Fabrication of avidin-stabilized gold nanoclusters with dual emissions and their application in biosensing by Zhenrong Tang, Fengjiao Chen, Dan Wang, Dongmei Xiong, Shaoying Yan, Shengchun Liu, Hua Tang

Get full text

Advanced technique of laser Doppler imaging for the diagnostics of intensity of peripheral microcirculation changes in patients with diffused liver diseases by T. D. Gelt, A. V. Borsukov

“…Identification of these changes may help predict disease course, the possibility of the therapy revising. 60 patients with alcoholic liver cirrhosis, steatohepatitis mixed etiology, viral hepatitis "B" and "C" were examined to evaluate the possibility of non-invasive laser Doppler imaging (LDI) offorecasting the course of various forms of diffuse liver disease. …”
Get full text

Functional analysis of pro-apoptotic activity of hepatitis B virus (HBV) : role of BcL2 homology domain 3 (BH3) in HBV DNA polymerase and HBX by Chen, William Wei Ning.

“…Hepatitis B virus (HBV) infection leads to a wide range of liver disease, including viral hepatitis and hepatocellular carcinoma (HCC). Viral hepatitis is characterized by an inflammatory reaction in the infected liver cells, and is associated with cell damage and death. …”
Get full text

Foetomaternal Outcomes of Jaundice in Pregnancy at a Tertiary Care Centre: A Prospective Cohort Study by Hasibul Hasan Shirazee, Firoza Yasmin, Faruk Hassan, Suvasmita Saha, Aparna Khan Mandal

“…Although viral hepatitis due to the faecooral route is more common in India, the present study showed that Hepatitis B is more common during pregnancy.…”
Get full text

FEATURES OF THE IMMUNE RESPONSE DURING VIRAL INFECTION by G. A. Borisov, A. A. Savchenko, Igor V. Kudryavtsev

“…Patients with acute and chronic viral infections (n = 896) were examined: 77 patients with acute viral hepatitis B, 94 — chronic viral hepatitis B, 119 — chronic hepatitis C, 531 — recurrent herpes, 75 — human papillomavirus infection. …”
Get full text

Prevalence of Blood-Borne Viral Infections (HIV, HBV, HCV) Among People Seeking Fertility Services in Ontario, Canada by Beth Rachlis, Elisa Candido, Heather Shapiro, Lisa Ishiguro, Jeff Kwong

“…We looked forward five years from a first BBVI test billed by a physician and assessed annual and cumulative testing prevalence and incidence of viral hepatitis and HIV using rule-based administrative algorithms. …”
Get full text

Transfusion Transmissible Infections in Blood Donors in the Province of Bié, Angola, during a 15-Year Follow-Up, Imply the Need for Pathogen Reduction Technologies by Luis Baião Peliganga, Vinicius Motta Mello, Paulo Sergio Fonseca de Sousa, Marco Aurelio Pereira Horta, Álvaro Domingos Soares, João Pedro da Silva Nunes, Miguel Nobrega, Lia Laura Lewis-Ximenez

Get full text

Reducing the risk of prenatal alcohol exposure and FASD through social services: promising results from the FAR SEAS pilot project by Katarzyna Okulicz-Kozaryn, Lidia Segura-García, Carla Bruguera, Fleur Braddick, Marta Zin-Sędek, Claudia Gandin, Luiza Słodownik-Przybyłek, Emanuele Scafato, Silvia Ghirini, Joan Colom, Silvia Matrai

Get full text